ShapiroHSingerPHalpernZBruckR. Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis. Gut. 2007;56(3):426-435.
2.
AtharMBackJHTangX. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol. 2007;224(3):274-283.
3.
BlockGJensenCDNorkusEP. Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study. Nutr J. 2007;6:30.
4.
RodrigoRMirandaAVergaraL. Modulation of endogenous antioxidant system by wine polyphenols in human disease. Clin Chim Acta. 2011;412(5-6):410-424.
5.
DasSDasDK. Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets. 2007;6(3):168-173.
6.
MartinARVillegasILa CasaCde la LastraCA. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem Pharmacol. 2004;67(7):1399-1410.
7.
MartinARVillegasISanchez-HidalgoMde la LastraCA. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br J Pharmacol. 2006;147(8):873-885.
8.
BaurJASinclairDA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5(6):493-506.
PetrovskiGGurusamyNDasDK. Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci. 2011;1215:22-33.
11.
KaminskiBMSteinhilberDSteinJMUlrichS. Phytochemicals resveratrol and sulforaphane as potential agents for enhancing the anti-tumor activities of conventional cancer therapies. Curr Pharm Biotechnol. 2011Apr5. [Epub ahead of print]
12.
UdenigweCCRamprasathVRAlukoREJonesPJ. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev. 2008;66(8):445-454.
13.
BrunoRGhisolfiLPriullaMNicolinABertelliA. Wine and tumors: study of resveratrol. Drugs Exp Clin Res. 2003;29(5-6):257-261.
14.
ParkJWChoiYJJangMA. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells. Cancer Lett. 2001;163(1):43-49.
15.
JazirehiARBonavidaB. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin’s lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther. 2004;3(1):71-84.
16.
DulakJ. Nutraceuticals as anti-angiogenic agents: hopes and reality. J Physiol Pharmacol. 2005;56(suppl 1):51-67.
17.
WalterRBBraskyTMMilanoFWhiteE. Vitamin, mineral, and specialty supplements and risk of hematologic malignancies in the prospective VITamins And Lifestyle (VITAL) study. Cancer Epidemiol Biomarkers Prev. 2011Aug23. [Epub ahead of print]
18.
FonarYFrankD. FAK and WNT signaling: the meeting of two pathways in cancer and development. Anticancer Agents Med Chem. 2011Jun27. [Epub ahead of print]
19.
NguyenAVMartinezMStamosMJ. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res. 2009;1: 25-37.
20.
JonesSBDePrimoSEWhitfieldMLBrooksJD. Resveratrol-induced gene expression profiles in human prostate cancer cells. Cancer Epidemiol Biomarkers Prev. 2005;14(3):596-604.
21.
SonnettTELevienTLGatesBJRobinsonJDCampbellRK. Diabetes mellitus, inflammation, obesity: proposed treatment pathways for current and future therapies. Ann Pharmacother. 2010;44(4):701-711.
22.
BrasnyóPMolnárGAMohásM. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr. 2011;106(3):383-389.
23.
DarveshASCarrollRTBishayeeAGeldenhuysWJVan der SchyfCJ. Oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agents. Expert Rev Neurother. 2010;10(5):729-745.
24.
PetroTM. Regulatory role of resveratrol on Th17 in autoimmune disease. Int Immunopharmacol. 2011;11(3):310-318.
25.
BeaudeuxJLNivet-AntoineVGiralP. Resveratrol: a relevant pharmacological approach for the treatment of metabolic syndrome?Curr Opin Clin Nutr Metab Care. 2010;13(6):729-736.
